These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6698110)
21. Protective actions of naloxone in hemorrhagic shock. Curtis MT; Lefer AM Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms of action of PGE1 in hemorrhagic shock in rats. Bitterman H; Stahl GL; Terashita Z; Lefer AM Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825 [TBL] [Abstract][Full Text] [Related]
23. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock. Bitterman H; Phillips GR; Dragon G; Lefer AM J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116 [TBL] [Abstract][Full Text] [Related]
24. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine. Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357 [TBL] [Abstract][Full Text] [Related]
25. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade. Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391 [TBL] [Abstract][Full Text] [Related]
26. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock. Bitterman H; Lefer DJ; Lefer AM Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971 [TBL] [Abstract][Full Text] [Related]
27. Salutary effects of anisodamine in murine traumatic shock. Hock CE; Su JY; Lefer AM Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878 [TBL] [Abstract][Full Text] [Related]
28. Restoration of renal and mesenteric hemodynamics by felodipine in a canine model of hemorrhagic shock. Sabouni M; Hodge K; Jandhyala BS Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):465-70. PubMed ID: 3405320 [TBL] [Abstract][Full Text] [Related]
29. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine. Galvin MJ; Lefer AM Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085 [No Abstract] [Full Text] [Related]
30. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock. Bitterman H; Stahl GL; Lefer AM Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456 [TBL] [Abstract][Full Text] [Related]
31. Arachidonic acid in splanchnic artery occlusion shock. Bridenbaugh GA; Flynn JT; Lefer AM Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849 [TBL] [Abstract][Full Text] [Related]
32. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs. Knorr A; Stoepel K Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298 [TBL] [Abstract][Full Text] [Related]
33. Effects of a calcium entry blocker on blood pressure and renal function during angiotensin-induced hypertension. Huelsemann JL; Sterzel RB; McKenzie DE; Wilcox CS Hypertension; 1985; 7(3 Pt 1):374-9. PubMed ID: 3158602 [TBL] [Abstract][Full Text] [Related]
34. Shock potentiating actions of angiotensin II infusion in cats. Trachte GJ; Lefer AM Circ Shock; 1980; 7(3):343-51. PubMed ID: 7449049 [TBL] [Abstract][Full Text] [Related]
35. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711 [TBL] [Abstract][Full Text] [Related]
36. Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F. Hall ED; Yonkers PA; McCall JM Eur J Pharmacol; 1988 Mar; 147(2):299-303. PubMed ID: 3366180 [TBL] [Abstract][Full Text] [Related]
38. Store-operated calcium channel inhibition attenuates neutrophil function and postshock acute lung injury. Lee C; Xu DZ; Feketeova E; Kannan KB; Fekete Z; Deitch EA; Livingston DH; Hauser CJ J Trauma; 2005 Jul; 59(1):56-63; discussion 63. PubMed ID: 16096539 [TBL] [Abstract][Full Text] [Related]
39. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock. Bitterman H; Smith BA; Lefer AM Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378 [TBL] [Abstract][Full Text] [Related]
40. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Bitterman H; Aoki N; Lefer AM Proc Soc Exp Biol Med; 1988 Jul; 188(3):265-71. PubMed ID: 3393543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]